ADVANCED FACILITY
Traditional growing in a GMP capable state of the art cultivation and processing facility supported by Canada's premier cultivation experts
Experion Receives Amended Sales License for Derivatives
June 8th, 2020
GROWING YOUR INVESTMENT THROUGH CANNABIS.
Experion is a Federally Licensed Cannabis company focused on distributing high quality cannabis products. With its state of the art facility, ability to source, process and distribute products nationally, is there opportunity? Plenty.
The underlying reason why investors originally invested in this sector remains the same: cannabis is and will continue to be a thriving multi-billion-dollar industry, with significant growth potential year over year.
There has never been a better time:
-
Cannabis consumers are projected to spend U.S. $5.2 billion in Canada by 2024
-
The medical marijuana market in Canada has the potential to be U.S. $1.88 billion by 2025
-
Global cannabis spending is expected to reach U.S. $66.3 billion by the end of 2025
Current markets
(TSXV:EXP) (OTCQB:EXPFF)
-
$0.0950
CURRENT ($)
-
0.00
24-hour Change ($)
-
0.00%
24-hour Change (%)
Experion advantages
Driving shareholder value through the distribution of quality cannabis products.
-
-
RESEARCH
Developing a bank of over 60 genetic strains and administering Canada's first Stage 3 clinical trial for pain management with cannabis
-
PARTNERSHIPS
Driving shareholder value through productive partnerships with only the best cannabis producers, discerning retailers and innovative manufacturers
-
GLOBAL EXPORT
Expertise, skill set and network to take advantage of global export opportunities
Press releases
-
-
Citizen Stash Enters the Province of Ontario
June 2nd, 2020
-
Experion Reports AGM Results
May 29th, 2020
-
Q2 2020 Strategic Update
May 25th, 2020
-
Experion reports revenue growth First quarter 2020 and fiscal 2019
May 12th, 2020
-
Experion Launches New Citizen Stash Branded Pre-Roll Line of Products
May 6th, 2020
Public filings
The numbers
-
$5.2B
Projected spend Adult-use cannabis in Canada by 2024 (USD)
-
$1.88B
Potential size of the Medical marijuana market in Canada by 2025 (USD)
-
$2.03B
Expected Canadian market size for alternative cannabis products annually starting 2020 (USD)
-
$66.3B
Global cannabis spend by the end of 2025 (USD)
THE KEY POINT
As the world continues to shift towards the legalization of cannabis, Experion has a unique advantage to distribute high quality flower and therapeutic products on a global platform
LET’S CONFIRM YOU’RE AT LEGAL AGE TO ENTER OUR SITE.
You must be of legal age in accordance with the law of your province to access this website and/or to purchase cannabis. By entering this site you agree to our terms and conditions and privacy policy.